The estimated Net Worth of Denise M. Bohnert is at least $1.49 Milione dollars as of 23 June 2022. Ms. Bohnert owns over 557 units of Amedisys stock worth over $1,146,132 and over the last 5 years she sold AMED stock worth over $342,374. In addition, she makes $0 as Chief Compliance Officer at Amedisys.
Denise has made over 9 trades of the Amedisys stock since 2020, according to the Form 4 filled with the SEC. Most recently she sold 557 units of AMED stock worth $64,055 on 23 June 2022.
The largest trade she's ever made was exercising 3,396 units of Amedisys stock on 12 February 2020 worth over $328,461. On average, Denise trades about 370 units every 41 days since 2020. As of 23 June 2022 she still owns at least 11,850 units of Amedisys stock.
You can see the complete history of Ms. Bohnert stock trades at the bottom of the page.
Denise Bohnert serves as Chief Compliance Officer of the Company since September 2019. She previously served as our Deputy Compliance Officer from January 2017 to August 31, 2019. Ms. Bohnert is responsible for managing and overseeing the compliance program, which is designed to promote ethical practices and compliance with state and federal healthcare laws and regulations. Ms. Bohnert also identifies potential compliance vulnerability and risks within the organization. Ms. Bohnert has over 15 years’ experience in healthcare and compliance. Before joining Amedisys in January 2017, Ms. Bohnert served as the Compliance Officer for Signature Healthcare in Louisville, Kentucky from January 2015 to December 2016, a skilled nursing facility and home health company. Ms. Bohnert was responsible for overseeing the compliance program which included the creation of regulatory policies and procedures, a compliance investigation structure and a staff of compliance professionals. From 2003 to December 2014, Ms. Bohnert worked at Kindred Healthcare in a variety of compliance and regulatory functions including Division Vice President of Risk and Compliance, Director of HIPAA Compliance (Privacy) and Risk Manager. Ms. Bohnert is both a registered nurse and licensed attorney earning her Bachelor of Science in Nursing from Indiana State University (Magna Cum Laude) and her Juris Doctor from Indiana University - Indianapolis. Ms. Bohnert also holds a Certification in Healthcare Compliance (CHC).
Denise Bohnert is 42, she's been the Chief Compliance Officer of Amedisys since 2019. There are 20 older and no younger executives at Amedisys. The oldest executive at Amedisys Inc. is Molly Coye, 72, who is the Independent Director.
Denise's mailing address filed with the SEC is 3854 AMERICAN WAY, SUITE A, , BATON ROUGE, LA, 70816.
Over the last 27 years, insiders at Amedisys have traded over $269,564,877 worth of Amedisys stock and bought 2,690,968 units worth $38,198,016 . The most active insiders traders include Asset Management Llc Kohlbe..., Tide Capital, Llc North Tid... e David Nierenberg. On average, Amedisys executives and independent directors trade stock every 29 days with the average trade being worth of $2,494,602. The most recent stock trade was executed by Richard M Ashworth on 26 December 2023, trading 11,237 units of AMED stock currently worth $896,937.
amedisys is a leading provider of healthcare in the home with a vision of becoming the premiere solution for patients across the country to age in place. from home health to hospice to personal care, amedisys team members provide quality, clinically-distinctive care to more than 376,000 patients every year. every life is precious and tells an incredible story, and we celebrate that each day by honoring our patients with genuine, personal attention. everything we do, from the boardroom to our nationwide network of care centers, is centered on the best care possible for those who have entrusted us with their well-being and comfort. we work closely with doctors and other healthcare providers to coordinate services, and every patient has an individual plan of care that meets their specific needs. amedisys recognizes that nothing we do is possible without our incredible team. for all employees, whether they’re on the front lines delivering direct care or supporting our clinical team, this i
Amedisys executives and other stock owners filed with the SEC include: